Item 8.01 Other Events.

On April 14, 2021, Greenwich LifeSciences, Inc. (the "Company") issued a press release announcing the publication of a second poster for the GP2 Phase III clinical trial design for recurring breast cancer at the 2021 AACR Annual Meeting. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.





(d) Exhibits.




Exhibit No.                Description

99.1            Press release dated April 14, 2021




  -2-

© Edgar Online, source Glimpses